FTC: Undisclosed AI Output Steering Is Consumer Deception, Comment Deadline Friday - techtimes.com
FTC warns that undisclosed AI output steering is considered consumer deception; comments due by Friday.
Aforeworn detected this change in the Healthcare AI Regulation (FDA / ONC) space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All businesses utilizing AI technologies in consumer-facing applications, particularly in healthcare. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Comment deadline is this Friday.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Healthcare AI Regulation (FDA / ONC) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FTC's stance on undisclosed AI output steering as deceptive, requiring transparency in AI-driven outputs.
Who it affects
All businesses utilizing AI technologies in consumer-facing applications, particularly in healthcare.
What you must do
Review AI systems for compliance with FTC guidelines on disclosure and prepare comments if necessary.
Deadline
Comment deadline is this Friday.
Never miss a change like this again
Aforeworn watches Healthcare AI Regulation (FDA / ONC) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Healthcare AI Regulation (FDA / ONC)
- Louisiana AI Legislative Update - pelicanpolicy.org
- New law aims to curb medical debt, increase transparency in hospital billing - indianapolisrecorder.com
- Illinois’ new AI therapy ban has a loophole - KevinMD.com
- New bill aims to safeguard health care licensing in Delaware - delawareonline.com
- FDA Grants Premarket Approval to AI-Enabled System for Breast Cancer Margin Assessment - targetedonc.com